Mealey's (December 18, 2019, 9:40 AM EST) -- BOSTON — The Massachusetts federal judge overseeing the Zofran birth defect multidistrict litigation on Dec. 13 asked the Food and Drug Administration to resolve a citizen petition “as expeditiously as possible” without regard to the impact of the decision on litigation (In Re: Zofran [Ondansetron] Products Liability Litigation, MDL Docket No. 15-md-2657, D. Mass.)....